标题 |
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
网址 | |
DOI |
10.1016/s1470-2045(22)00224-8
doi
|
其它 |
期刊:Lancet Oncology 作者:Jie Wang; Caicun Zhou; Wenxiu Yao; Qiming Wang; Xuhong Min; et al 出版日期:2022-05-13 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |